Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMGN
AMGN logo

AMGN News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AMGN News

Amgen Rated Among High Yield Fortune 500 Stocks

5d agoYahoo Finance

Future Outlook for Obesity Drugs Market

6d agoCNBC

Future Outlook for Obesity Medications

6d agoNewsfilter

AbbVie Showcases New Data in Blood Cancer Portfolio

Jun 12 2026Fool

AbbVie Expands Blood Cancer Treatment Market with New Data

Jun 12 2026NASDAQ.COM

Amgen Re-evaluates Tavneos Data Amid FDA Concerns

Jun 11 2026seekingalpha

Amgen Rated Among Most Profitable Dividend Stocks

Jun 09 2026Yahoo Finance

Amgen Reports Positive VESALIUS-CV Trial Results for Repatha

Jun 08 2026NASDAQ.COM

AMGN Events

No data

No data

AMGN Monitor News

Amgen's Repatha Shows Significant Cardiovascular Benefits

Jun 11 2026

Amgen's IMDYLLTRA Approved by EU for Lung Cancer Treatment

Jun 05 2026

Amgen Reports Q1 Earnings Beat and Upgraded Outlook

May 01 2026

Amgen Reports Strong Q4 Results Exceeding Expectations

Feb 06 2026

Amgen Reports Strong Q4 Results Exceeding Expectations

Feb 04 2026

Amgen Faces Lawsuit Over Discount Drug Sales Termination

Jan 21 2026

Amgen's Stock Rises After Major Acquisition and Partnership Announcements

Jan 07 2026

AMGN Earnings Analysis

Amgen Q3 2025 Earnings: Growth and Outlook- Intellectia AI™
7 months ago
Amgen's Strong Performance Continues with Impressive Earnings in Q4 2024 - Intellectia AI™
1 years ago
Amgen Inc Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch